Susquehanna International Group, LLP Geo Vax Labs, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$0.62 - $1.11 $17,098 - $30,611	-27,578 Reduced 67.33%	13,383 $8,000
Q4 2022 Feb 14, 2023	BUY	$0.55 - $17.1 $22,528 - $700,433	40,961 New	40,961 $25,000
Q1 2022 May 16, 2022	SELL	$17.25 - $58.95 $198,323 - $677,748	-11,497 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$52.65 - $71.7 $605,317 - $824,334	11,497 New	11,497 $42,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.